Recent News

Why is breast cancer mortality higher for African-American women than for white women?

Graduate Students from Aneja lab presented at the Tenth AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved

1. β-catenin overexpression underlies the aggressive disease course in African American triple negative breast cancer patients that lack androgen receptor– presented by Karuna Mittal 2. Differences in tumor infiltrating lymphocytes between racially-distinct triple negative breast tumors Presented by Nikita Wright.

A new clue into treatments for triple negative breast cancer, a mean disease

Georgia State hosts first International Triple Negative Breast Cancer Conference

Things to be aware of all year about breast cancer

Aneja Lab Recognized in the Atlanta Business Chronicle for Triple Negative Breast Cancer Research Cover page: Inside article:

Lack of Androgen Receptor Protein May Contribute to Racial Disparities in Triple Negative Breast Cancer Outcomes

Triple-negative breast cancer (TNBC) in African-American women is much more likely to lack the androgen receptor protein compared with TNBC in European-American women, and this may contribute to the racial disparity in survival outcomes among these two populations, according to a study presented at the Ninth AACR Conference on The Science of Cancer Health DisparitiesRead More